1. Home
  2. ATNM vs DUO Comparison

ATNM vs DUO Comparison

Compare ATNM & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.01

Market Cap

33.9M

Sector

Health Care

ML Signal

HOLD

DUO

Fangdd Network Group Ltd.

HOLD

Current Price

$0.88

Market Cap

38.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
DUO
Founded
2000
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
33.9M
38.5M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
ATNM
DUO
Price
$1.01
$0.88
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
105.6K
112.9K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
14.17
N/A
EPS
N/A
N/A
Revenue
$90,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$0.95
$0.71
52 Week High
$1.89
$5.34

Technical Indicators

Market Signals
Indicator
ATNM
DUO
Relative Strength Index (RSI) 36.37 30.92
Support Level $0.99 N/A
Resistance Level $1.27 $1.25
Average True Range (ATR) 0.07 0.12
MACD -0.02 -0.02
Stochastic Oscillator 0.10 34.75

Price Performance

Historical Comparison
ATNM
DUO

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China. All revenues of the Group are derived from the PRC.

Share on Social Networks: